Review
Published on 17 Aug 2021
Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
in Endocrinology of Aging
Frontiers in Endocrinology
doi 10.3389/fendo.2021.731273
- 9,074 views
- 22 citations
19 articles related to "Dpp4 Inhibitors"
Articles
Systematic Review
Published on 12 Oct 2022
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.994944
- 3,752 views
- 6 citations
Systematic Review
Published on 10 Jul 2019
Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00777
- 4,976 views
- 12 citations
Systematic Review
Published on 09 Aug 2022
Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.935039
- 4,462 views
- 6 citations
Review
Published on 02 May 2022
The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism
in Bone Research
Frontiers in Endocrinology
doi 10.3389/fendo.2022.856954
- 6,362 views
- 26 citations
Review
Published on 09 Dec 2021
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.731453
- 20,266 views
- 66 citations
Systematic Review
Published on 10 Aug 2023
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1203187
- 3,984 views
- 5 citations
Review
Published on 07 Dec 2020
The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy
in Clinical and Translational Physiology
Frontiers in Physiology
doi 10.3389/fphys.2020.603247
- 10,165 views
- 28 citations
Original Research
Published on 05 Jan 2023
Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.1084960
- 3,971 views
- 7 citations
Case Report
Published on 29 Jul 2024
A case report of dipeptidyl peptidase 4 inhibitor-related kidney disease combined with renal cancer
in Clinical Research in Nephrology
Frontiers in Nephrology
doi 10.3389/fneph.2024.1409098
- 1,763 views
- 1 citation
Original Research
Published on 15 Jan 2026
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1647342
- 1,135 views
Original Research
Published on 31 Mar 2020
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2020.00405
- 10,165 views
- 40 citations
Original Research
Published on 06 Nov 2023
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1245642
- 4,094 views
- 6 citations
Original Research
Published on 30 May 2022
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.871052
- 3,715 views
- 2 citations
Review
Published on 19 Jan 2022
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.807548
- 87,492 views
- 246 citations
Review
Published on 23 Feb 2023
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1138499
- 20,843 views
- 59 citations